Skip to main content
. 2015 Feb 1;41(2):338–345. doi: 10.1093/schbul/sbu222

Table 1.

Demographic and Clinical Characteristics, Mean (SD)

Characteristic Controls Patients F/X 2 P
No. (%) male 26 (59) 28 (63) 0.15 .83
Age (y) 38.77 (13.58) 37.96 (11.17) 0.10 .99
Education (y) 14.14 (2.66) 13.58 (3.03) 0.87 .99
TONI index 110.60 (10.33) 97.73 (11.03) 31.09 <.001
Digit span 5.36 (0.78) 4.37 (1.22) 20.47 <.001
AIMS 0.15 (0.71) 2.33 (3.86) 10.19 .02
BFCRS 0 (0) 1.63 (3.58) 9.12 .03
UPDRS III 0 (0) 7.09 (7.29) 41.56 <.001
NES 3.94 (4.84) 13.59 (11.45) 21.26 <.001
MRS 0 (0) 2.80 (5.21) 12.72 .006
FAB 17.57 (0.66) 16.16 (2.64) 11.90 .009
TLC 6.20 (7.72)
SANS 24.87 (16.93)
CAINS 17.96 (10.67)
PANSS positive 18.00 (6.13)
PANSS negative 18.33 (5.13)
PANSS general 35.43 (8.36)
CPZ (mg) 403.22 (346.98)
Duration of illness (y) 12.89 (12.08)

Note: AIMS, Abnormal Involuntary Movement Scale; BFCRS, Bush Francis Catatonia Rating Scale; UPDRS III, motor part of the Unified Parkinson’s Disease Rating Scale; NES, Neurological Evaluation Scale; MRS, Modified Rogers Scale; FAB, Frontal Assessment Battery; TLC, Thought Language and Communication Scale; SANS, Scale for the Assessment of the Negative Syndrome; CAINS, Clinical Assessment Interview for Negative Symptoms; PANSS, Positive and Negative Syndrome Scale; P values adjusted for multiple comparisons.

HHS Vulnerability Disclosure